Hartford Funds Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $992K | Buy |
14,200
+1,317
| +10% | +$92K | 0.09% | 48 |
|
|
2025
Q1 | $947K | Buy |
12,883
+1,645
| +15% | +$121K | 0.09% | 49 |
|
|
2024
Q4 | $736K | Buy |
11,238
+598
| +6% | +$39.2K | 0.07% | 60 |
|
|
2024
Q3 | $829K | Buy |
10,640
+251
| +2% | +$19.6K | 0.08% | 52 |
|
|
2024
Q2 | $810K | Buy |
10,389
+949
| +10% | +$74K | 0.08% | 49 |
|
|
2024
Q1 | $640K | Buy |
9,440
+1,417
| +18% | +$96K | 0.06% | 54 |
|
|
2023
Q4 | $540K | Buy |
8,023
+2,234
| +39% | +$150K | 0.05% | 53 |
|
|
2023
Q3 | $392K | Buy |
5,789
+327
| +6% | +$22.1K | 0.04% | 48 |
|
|
2023
Q2 | $391K | Buy |
5,462
+672
| +14% | +$48.1K | 0.04% | 46 |
|
|
2023
Q1 | $332K | Buy |
4,790
+956
| +25% | +$66.4K | 0.03% | 52 |
|
|
2022
Q4 | $260K | Buy |
+3,834
| New | +$260K | 0.03% | 51 |
|